PLx Pharma Inc (PLXP):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PLx Pharma Inc (PLXP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7581
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PLx Pharma Inc (PLx Pharma) is a pharmaceutical company that develops patent-protected delivery systems. The company offers products such as PLxGuard delivery system, PLxGuard pipeline products, and PL1100 and PL1200 ibuprofen products. Its PLxGuard delivery system are used in enhancement of efficacy of drugs, GI safety development, new or extended patent protection, and new drug application solutions. PLx Pharma’s lead product candidate include Aspertec 325 mg, which is a novel formulations of aspirin that uses PLxGuard delivery system to reduce acute gastrointestinal side effects while providing antiplatelet effectiveness for cardiovascular disease prevention. It also offers publications and research services. The company serves healthcare professionals. PLx Pharma is headquartered in Houston, Texas, the US.

PLx Pharma Inc (PLXP) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PLx Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PLx Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PLx Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PLx Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PLx Pharma Inc, Medical Devices Deals, 2012 to YTD 2018 9
PLx Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
PLx Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
PLx Pharma Raises USD1.3 Million in Venture Financing 11
PLx Pharma Raises USD9 Million in Extended Series E Financing 12
PLx Pharma Raises USD8.27 Million in Series E Financing 13
Merger 14
Dipexium Pharma Merges with PLx Pharma 14
Licensing Agreements 16
PLx Pharma Enters into Licensing Agreement with Lee’s Pharma for Cardiovascular Product 16
Equity Offering 18
PLx Pharma Raises USD18.2 Million in Private Placement of Shares 18
PLx Pharma Withdraws IPO 20
PLx Pharma Inc – Key Competitors 22
PLx Pharma Inc – Key Employees 23
PLx Pharma Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Aug 10, 2018: PLx Pharma reports second quarter 2018 results 25
May 11, 2018: PLx Pharma Inc. Reports First Quarter 2018 Results 27
May 11, 2018: PLx Pharma Reports First Quarter 2018 Results 28
Mar 23, 2018: PLx Pharma Reports Fourth Quarter and Full Year 2017 Results 29
Nov 09, 2017: PLx Pharma Reports Third Quarter 2017 Results 31
Aug 10, 2017: PLx Pharma Reports Second Quarter 2017 Results 33
May 02, 2017: Rita M. O Connor Appointed Chief Financial Officer of PLx Pharma 34
Corporate Communications 35
May 01, 2017: PLx Pharma appoints vice president of sales and marketing 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
PLx Pharma Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
PLx Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PLx Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PLx Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PLx Pharma Inc, Deals By Therapy Area, 2012 to YTD 2018 8
PLx Pharma Inc, Medical Devices Deals, 2012 to YTD 2018 9
PLx Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
PLx Pharma Raises USD1.3 Million in Venture Financing 11
PLx Pharma Raises USD9 Million in Extended Series E Financing 12
PLx Pharma Raises USD8.27 Million in Series E Financing 13
Dipexium Pharma Merges with PLx Pharma 14
PLx Pharma Enters into Licensing Agreement with Lee's Pharma for Cardiovascular Product 16
PLx Pharma Raises USD18.2 Million in Private Placement of Shares 18
PLx Pharma Withdraws IPO 20
PLx Pharma Inc, Key Competitors 22
PLx Pharma Inc, Key Employees 23
PLx Pharma Inc, Other Locations 24

List of Figures
PLx Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PLx Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PLx Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PLx Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PLx Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PLx Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PLx Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PLx Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PLx Pharma Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[PLx Pharma Inc (PLXP):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Harte Hanks Inc (HHS):企業の財務・戦略的SWOT分析
    Harte Hanks Inc (HHS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ITC Holdings Corp.:電力:M&Aディール及び事業提携情報
    Summary ITC Holdings Corp. (ITC Holdings), an indirect subsidiary of Fortis Inc, is an independent electricity transmission company. It owns, operates, maintains, and invests in transmission infrastructure. The company harnesses system integrity and reliability, reduces transmission constraints, all …
  • Coca-Cola Consolidated Inc (COKE):企業の財務・戦略的SWOT分析
    Coca-Cola Consolidated Inc (COKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Moss Bros Group Plc (MOSB):企業の財務・戦略的SWOT分析
    Moss Bros Group Plc (MOSB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Aon Plc:企業の戦略・SWOT・財務分析
    Aon Plc - Strategy, SWOT and Corporate Finance Report Summary Aon Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • AIG Europe Limited:企業の戦略・SWOT・財務情報
    AIG Europe Limited - Strategy, SWOT and Corporate Finance Report Summary AIG Europe Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • The People’s Insurance Company (Group) of China Limited:戦略・SWOT・企業財務分析
    The People's Insurance Company (Group) of China Limited - Strategy, SWOT and Corporate Finance Report Summary The People's Insurance Company (Group) of China Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • PT. SOHO Industri Pharmasi:製薬・医療:M&Aディール及び事業提携情報
    Summary PT. SOHO Industri Pharmasi (PT SOHO), a subsidiary of SOHO Global Health, is a pharmaceutical company that offers ethical, consumer health, herbal medicine and natural products. The company’s products include analgesic, anti-inflammatory, antipyretic, antibiotics, antifungal, antihistamine a …
  • Aoyama Trading Co., Ltd.:企業の戦略・SWOT・財務分析
    Aoyama Trading Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aoyama Trading Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Deluxe Corporation:企業の戦略・SWOT・財務情報
    Deluxe Corporation - Strategy, SWOT and Corporate Finance Report Summary Deluxe Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Power Corporation of Canada:企業の戦略・SWOT・財務分析
    Power Corporation of Canada - Strategy, SWOT and Corporate Finance Report Summary Power Corporation of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Santos Ltd (STO):企業の財務・戦略的SWOT分析
    Santos Ltd (STO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Bayshore Petroleum Corp (BSH):石油・ガス:M&Aディール及び事業提携情報
    Summary Bayshore Petroleum Corp (Bayshore Petroleum) is an oil and gas company that explores, produces, and develops natural gas and petroleum. The company develops conventional and unconventional oil and gas prospects in North America and across the world. Its CCC technology provides heavy oil and …
  • Novus Therapeutics Inc (NVUS):製薬・医療:M&Aディール及び事業提携情報
    Summary Novus Therapeutics Inc (Tokai Pharma), formerly Tokai Pharmaceuticals Inc is a pharmaceutical company that develops products for ear, nose and throat. The company’s lead products is a nasally-administer, combination drug product and eustachian tube dysfunction, among others. Its galeterone i …
  • Hallmark Cards, Inc.:企業の戦略・SWOT・財務情報
    Hallmark Cards, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hallmark Cards, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Carl Zeiss AG:企業の戦略的SWOT分析
    Carl Zeiss AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Molinos Rio de la Plata SA (MOLI3):企業の財務・戦略的SWOT分析
    Molinos Rio de la Plata SA (MOLI3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Borges International Group SLU:企業の戦略的SWOT分析
    Borges International Group SLU - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Wells Fargo & Company:企業のM&A・事業提携・投資動向
    Wells Fargo & Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wells Fargo & Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • The Cheesecake Factory Incorporated:企業の戦略・SWOT・財務情報
    The Cheesecake Factory Incorporated - Strategy, SWOT and Corporate Finance Report Summary The Cheesecake Factory Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆